BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Li S, Ge Y, Kang J, Liao JF, Du JF, Tian J, Xie X, Li F. iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis. J Inflamm Res 2021;14:6993-7006. [PMID: 34955646 DOI: 10.2147/JIR.S340351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Huang X, Qi B, Sun C, Sun K, Liu N, Zhu L, Wei X. Ferroptosis and musculoskeletal diseases: “Iron Maiden” cell death may be a promising therapeutic target. Front Immunol 2022;13:972753. [DOI: 10.3389/fimmu.2022.972753] [Reference Citation Analysis]
2 Madrid-paredes A, Martín J, Márquez A. -Omic Approaches and Treatment Response in Rheumatoid Arthritis. Pharmaceutics 2022;14:1648. [DOI: 10.3390/pharmaceutics14081648] [Reference Citation Analysis]
3 Chang S, Tang M, Zhang B, Xiang D, Li F. Ferroptosis in inflammatory arthritis: A promising future. Front Immunol 2022;13:955069. [DOI: 10.3389/fimmu.2022.955069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]